HAMILTON, Bermuda--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV; BSX: COV) today reported results for the third quarter of fiscal 2008 (April – June 2008). Third-quarter net sales rose 14% to $2.6 billion from $2.3 billion a year ago, fueled by strong growth in the Medical Devices, Imaging Solutions and Pharmaceutical Products business segments. Sales growth was driven by higher volume and new products. Favorable foreign exchange contributed 5 percentage points to the sales increase. All International regions -- Europe, Japan, Other Americas and Asia-Pacific -- reported strong double-digit sales gains.
